Follow up of HIV-infected patients on antiretroviral treatment
Chirouze, C.; Hoen, B.
La Revue du Praticien 56(9): 966-975
2006
ISSN/ISBN: 0035-2640 PMID: 16775977 Document Number: 604897
Highly-active antiretroviral treatments have profoundly modified the course the HIV infection. Treating HIV-infected patients now means treating patients with a chronic disease. From now on, alongside with the immunovirological aspects, it has become necessary to take into account the adverse effects of the treatments, the problems of therapeutic adherence and comorbidities. It is indeed possible to simplify or to change the treatment according to the problem encountered and to the patient's immunovirological answer. As far as interrupting the treatment is concerned, strategies are still being studied. The immunologic restoration under antiretroviral treatment makes possible for the physicians to stop the chimioprophylaxies given against the opportunist infections.
Document emailed within 1 workday
Related Documents
Tweya, H.; Feldacker, C.; Estill, J.; Jahn, A.; Ng'ambi, W.; Ben-Smith, A.; Keiser, O.; Bokosi, M.; Egger, M.; Speight, C.; Gumulira, J.; Phiri, S. 2013: Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi Plos one 8(9): E75761Baesi, K.; Ravanshad, M.; Ghanbarisafari, M.; Saberfar, E.; Seyedalinaghi, S.; Volk, J.E. 2014: Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran Journal of Medical Virology 86(7): 1093-1098
Geng, E.H.; Glidden, D.V.; Emenyonu, N.; Musinguzi, N.; Bwana, M.B.; Neilands, T.B.; Muyindike, W.; Yiannoutsos, C.T.; Deeks, S.G.; Bangsberg, D.R.; Martin, J.N. 2010: Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa Tropical Medicine and International Health: Tm and Ih 15(Suppl 1): 63-69
Schöni-Affolter, F.; Keiser, O.; Mwango, A.; Stringer, J.; Ledergerber, B.; Mulenga, L.; Bucher, H.C.; Westfall, A.O.; Calmy, A.; Boulle, A.; Chintu, N.; Egger, M.; Chi, B.H.; Barth, J.; Battegay, M.; Bernasconi, E.; Böni, J.; Bucher, H.C.; Bürgisser, P.; Burton-Jeangros, C.; Calmy, A.; Cavassini, M.; Egger, M.; Elzi, L.; Fehr, J.; Flepp, M.; Francioli, P.; Furrer, H.; Fux, C.A.; Gorgievski, M.; Günthard, H.; Hasse, B.; Hirsch, H.H.; Hirschel, B.; Hösli, I.; Kahlert, C.; Kaiser, L.; Kaiser, O.; Kind, C.; Klimkait, T.; Kovari, H.; Ledergerber, B.; Martinetti, G.; Tejada, B.M.d.; Müller, N.; Nadal, D.; Pantaleo, G.; Rauch, A.; Regenass, S.; Rickenbach, M.; Rudin, C.; Schmid, P.; Schultze, D.; Schöni-Affolter, F.; Schüpbach, J.; Speck, 2011: Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland Plos one 6(12): E27919
Liu, C.-F.; Weng, S.-F.; Lin, Y.-S.; Lin, C.-S.; Lien, C.-F.; Wang, J.-J. 2013: Increased risk of deep neck infection among HIV-infected patients in the era of highly active antiretroviral therapy--a population-based follow-up study Bmc Infectious Diseases 13: 183
Errol, L.; Isaakidis, P.; Zachariah, R.; Ali, M.; Pilankar, G.; Maurya, S.; Geraets, C.; Ladomirska, J.; Patel, S.; Reid, T. 2012: Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India Journal of Advanced Nursing 68(11): 2399-2409
Miller, C.M.; Ketlhapile, M.; Rybasack-Smith, H.; Rosen, S. 2010: Why are antiretroviral treatment patients lost to follow-up? a qualitative study from South Africa Tropical Medicine and International Health: Tm and Ih 15(Suppl 1): 48-54
Schwenk, A.; Beisenherz, A.; Kremer, G.; Diehl, V.; Salzberger, B.; Fätkenheuer, G. 1999: Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment American Journal of Clinical Nutrition 70(5): 867-873
Choun, K.; Thai, S.; Pe, R.; Lorent, N.; Lynen, L.; van Griensven, J. 2013: Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia Transactions of the Royal Society of Tropical Medicine and Hygiene 107(4): 235-242
Deribew, A.; Deribe, K.; Reda, A.A.; Tesfaye, M.; Hailmichael, Y.; Maja, T. 2013: Do common mental disorders decline over time in TB/HIV co-infected and HIV patients without TB who are on antiretroviral treatment? Bmc Psychiatry 13: 174
Agbaji, O.O.; Abah, I.O.; Falang, K.D.; Ebonyi, A.O.; Musa, J.; Ugoagwu, P.; Agaba, P.A.; Sagay, A.S.; Jolayemi, T.; Okonkwo, P.; Idoko, J.A.; Kanki, P.J. 2015: Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria Current HIV Research 13(3): 184-192
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Tuboi, S.H.; Brinkhof, M.W.G.; Egger, M.; Stone, R.A.; Braitstein, P.; Nash, D.; Sprinz, E.; Dabis, Fçois.; Harrison, L.H.; Schechter, M. 2007: Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration Journal of Acquired Immune Deficiency Syndromes 45(1): 52-59
Tuboi, S.H.; Brinkhof, M.W.G.; Egger, M.; Stone, R.A.; Braitstein, P.; Nash, D.; Sprinz, E.; Dabis, Fçois.; Harrison, L.H.; Schechter, M. 2007: Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration Journal of Acquired Immune Deficiency Syndromes 45(1): 52-59
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Baiocchi, O.C.G.; Colleoni, G.W.B.; Navajas, E.V.; Duarte, L.Claudio.C.; Alves, A.C.; Andrade, A.Lucia.S.S.; Kerbauy, J.; Oliveira, J.Salvador.R. 2002: Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma Acta Oncologica 41(2): 192-196
Mberi, M.Naome.; Kuonza, L.Rugare.; Dube, N.Michelle.; Nattey, C.; Manda, S.; Summers, R. 2015: Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study BMC health services research 15: 259
Tweya, H.; Gareta, D.; Chagwera, F.; Ben-Smith, A.; Mwenyemasi, J.; Chiputula, F.; Boxshall, M.; Weigel, R.; Jahn, A.; Hosseinipour, M.; Phiri, S. 2010: Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi Tropical Medicine and International Health: Tm and Ih 15(Suppl 1): 82-89
Satti, H.; McLaughlin, M.M.; Hedt-Gauthier, B.; Atwood, S.S.; Omotayo, D.B.; Ntlamelle, L.; Seung, K.J. 2012: Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho Plos one 7(10): E46943
Monteny, M.; Kroes, A.C.; Groeneveld, P.H.; Kroon, F.P. 1998: Virological evaluation of the treatment of HIV-infected patients with (combinations of) antiretroviral agents in the Academic Medical Center of Amsterdam Nederlands Tijdschrift Voor Geneeskunde 142(20): 1169-1170